In this issue:
Environmental toxic metal contaminants and CV disease
Influence of bodyweight on the efficacy of aspirin
CTCA + standard care improves 5-year outcomes in chest pain patients
Haemodynamic valve deterioration after bioprosthetic AVR
Omega-3 fatty acids reduce peripheral arterial disease
Percutaneous repair vs medical treatment for secondary mitral regurgitation
Transcatheter mitral-valve repair in patients with HF
Supplemental oxygen therapy in patients with suspected AMI
Further lowering of LDL-C in patients with already low levels
One-year outcomes after PCI for AMI and cardiogenic shock
Please login below to download this issue (PDF)